Cue Advisory Services’s Biogen BIIB Stock Holding History

Cue Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,710	Closed	-$604K	–	16
2018 Q3	$604K	Sell	1,710 -70	-4%	-$24.1K	0.36%	96
2018 Q2	$517K	Buy	1,780 +105	+6%	+$29.5K	0.32%	112
2018 Q1	$459K	Buy	1,675 +47	+3%	+$14.6K	0.3%	111
2017 Q4	$519K	Buy	1,628 +165	+11%	+$52.9K	0.34%	104
2017 Q3	$458K	Sell	1,463 -270	-16%	-$80K	0.32%	108
2017 Q2	$470K	Buy	1,733 +25	+1%	+$6.61K	0.34%	102
2017 Q1	$467K	Buy	1,708 +35	+2%	+$9.9K	0.35%	101
2016 Q4	$474K	Buy	1,673 +10	+0.6%	+$2.96K	0.38%	98
2016 Q3	$521K	Sell	1,663 -169	-9%	-$50.1K	0.44%	89
2016 Q2	$443K	Buy	1,832 +540	+42%	+$142K	0.38%	93
2016 Q1	$336K	Buy	1,292 +70	+6%	+$18.5K	0.29%	106
2015 Q4	$374K	Buy	1,222 +242	+25%	+$69.5K	0.34%	97
2015 Q3	$286K	Hold	980	–	–	0.3%	104
2015 Q2	$396K	Hold	980	–	–	0.37%	99
2015 Q1	$413K	Hold	980	–	–	0.42%	91
2014 Q4	$333K	Buy	+980	New	+$317K	0.35%	105

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cue Advisory Services's BIIB Position: Q4 2018 in Review

Cue Advisory Services sold out of Biogen (BIIB) in Q4 2018, closing a stake of 1,710 shares — an estimated $604K sold.

Cue Advisory Services first reported a position in BIIB in Q4 2014 and held it in 16 quarters. The position peaked at $604K in Q3 2018. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

Cue Advisory Services reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
Cue Advisory Services sold 1,710 Biogen shares in Q4 2018, an estimated $604K.
Cue Advisory Services first reported a position in Biogen in Q4 2014 and held it in 16 quarters.
Cue Advisory Services's Biogen position peaked at $604K in Q3 2018.
1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Cue Advisory Services's 13F filing for Q4 2018.